A European Multicenter Open-label Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients

Mise à jour : Il y a 4 ans
Référence : EUCTR2008-001841-24

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective of the study is to compare the percentage of patients reaching an effective fentanyl buccal tablet (FBT) dose with a starting dose of 100 mcg (Group A) to those with a starting dose of 200 mcg (Group B).


Critère d'inclusion

  • Breakthrough Pain (BTP) in cancer patients